Investment Rating - The report maintains an "Outperform" rating for the company [2][7]. Core Insights - The company is expected to achieve a significant increase in net profit for the first half of 2025, with estimates ranging from 1.97 to 2.13 billion yuan, representing a year-on-year growth of 136% to 155% [7]. - The price of refrigerants continues to rise significantly, with the average sales price in Q2 2025 increasing by 65% year-on-year [7]. - The company is well-positioned to benefit from the upward trend in refrigerant prices due to its leading production quotas for second and third-generation refrigerants [7]. Financial Data and Profit Forecast - Total revenue is projected to grow from 24.46 billion yuan in 2024 to 33.82 billion yuan by 2027, with a compound annual growth rate (CAGR) of approximately 10.6% [3]. - Net profit attributable to the parent company is forecasted to increase from 1.96 billion yuan in 2024 to 7.57 billion yuan in 2027, reflecting a CAGR of 30% [3]. - Earnings per share (EPS) is expected to rise from 0.73 yuan in 2024 to 2.80 yuan in 2027 [3]. Market Data - As of July 9, 2025, the closing price of the stock was 27.55 yuan, with a market capitalization of 74.38 billion yuan [4]. - The stock has a price-to-earnings (P/E) ratio of 16 for 2025, which is projected to decrease to 10 by 2027 [3][4]. Segment Performance - The sales volume of fluorinated refrigerants in Q2 2025 was 84,800 tons, with a significant increase in sales price [7]. - The company’s fluorinated polymer materials and fine chemicals segments are showing signs of recovery, with sales volumes increasing by 5% and 12% year-on-year, respectively [7].
巨化股份(600160):制冷剂价格环比继续大幅上扬,全球“特许经营权”属性价值凸显